Post-Surgery Glucose Management: Why It's Critical for Recovery

The Metabolic Rationale for Perioperative Glucose Control

Surgery triggers a catabolic stress response—cortisol, catecholamines, and cytokines surge, driving insulin resistance and hyperglycemia. Exogenous glucose administration serves multiple protective roles.

1. Immediate Energy Substrate

Glucose is the brain's obligate fuel and preferred substrate for healing tissues. Post-op glycogen stores are depleted; IV dextrose prevents catabolism of lean muscle for gluconeogenesis.

2. Hypoglycemia Prevention

Anesthesia, NPO status, and insulin infusion protocols increase hypoglycemia risk. Maintenance dextrose (e.g., D5W at 50–100 mL/hr) stabilizes glycemia, especially in diabetics and pediatric patients.

3. Vital Organ Support

• Brain: Prevents neuroglycopenia.
• Heart: Myocardium uses glucose efficiently under ischemic stress.
• Immune cells: Neutrophils and macrophages rely on glycolysis for phagocytosis and oxidative burst.

4. Wound Healing Promotion

Fibroblast proliferation, collagen synthesis, and angiogenesis are energy-intensive. Adequate glucose availability accelerates tensile strength gain.

5. Stress Response Modulation

Controlled glucose infusion attenuates counter-regulatory hormone spikes, reducing protein breakdown and immunosuppression.

6. Immune Function Preservation

Hyperglycemia (>180 mg/dL) impairs neutrophil function; hypoglycemia (<70 mg/dL) impairs cognition and cardiac stability. Target: 110–180 mg/dL (per ADA/SCIP).

7. Monitoring and Individualization

• Point-of-care glucose q1–2h initially.
• Insulin infusion protocols for tight control in cardiac, transplant, and critical care.
• Transition to subcutaneous regimen before discharge.

Bottom line: Perioperative glucose isn't just "sugar water"—it's a targeted metabolic intervention that reduces complications, supports healing, and shortens recovery.